To analyze the impacts of combination therapy on the infiltration of CD8T cells in the TME and the expression of CCL5 and CYP1A1 in residual tumor tissue, we stained the slices of 24 specimens with mIHC (eight samples obtained from direct surgery and 16 surgical samples obtained after combination therapy). The gene discussed is CYP1A1; the disease is neoplasm.